Eli Lilly, a US drugmaker, lobbied for 3.3 million dollar in the third quarter of 2008 on issues, which include counterfeiting problems and regulatory reform in China, according to the Associated Press. Read the AP article via the site of Forbes here.
Thursday, December 18, 2008
"Eli Lilly Lobbies on Counterfeiting And Regulatory Issues Involving China"
Eli Lilly, a US drugmaker, lobbied for 3.3 million dollar in the third quarter of 2008 on issues, which include counterfeiting problems and regulatory reform in China, according to the Associated Press. Read the AP article via the site of Forbes here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment